Antilymphoblast globulin treatment of steroid-resistant rejection in cyclosporine-immunosuppressed renal transplant recipients.
Tellis
V A
VA
Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY 10467.
Matas
A J
AJ
Quinn
T A
TA
Glicklich
D
D
Weiss
R J
RJ
Soberman
R J
RJ
Veith
F J
FJ
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use*; D004351:Drug Resistance; D005260:Female; D006084:Graft Rejection / Q000276:immunology*; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D013256:Steroids / Q000627:therapeutic use
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D013256:Steroids